Item does not contain fulltextWe investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinson's disease (PD; n = 35) and multiple system atrophy (MSA; n = 30). The median CSF concentration of the neurotransmitter metabolites 5-hydroxyindolacetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) was reduced significantly (49-70%) in MSA compared to PD. In contrast, several brain-specific proteins (tau, neuron-specific enolase, myelin basic protein) were elevated (130-230%) in MSA compared with those in PD. A combination of CSF tau and MHPG discriminated PD from MSA (adjusted odds ratios: tau, 27.2; MHPG, 0.14). Our data suggest that the more progressive and widespread neurodegenerative nat...
Differentiating corticobasal syndrome (CBS) from progressive supranuclear palsy (PSP) and idiopathic...
Background: Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atro...
Background: Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atro...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
Objective. To investigate the differences of candidate cerebrospinal fluid (CSF) biomarkers associat...
Contains fulltext : 52941.pdf (publisher's version ) (Closed access)BACKGROUND: Mu...
BACKGROUND: In early disease stages it can be clinically difficult to differentiate idiopathic Parki...
Contains fulltext : 52942.pdf (publisher's version ) (Closed access)BACKGROUND: In...
BACKGROUND: Multiple system atrophy (MSA) can clinically be divided into the cerebellar (MSA-C) and ...
Contains fulltext : 97710.pdf (publisher's version ) (Closed access)Differentiatin...
Background: Parkinson’s disease (PD) and atypical parkinsonian disorders (APD) [multiple system atro...
Introduction: Neuroinflammation is a potential player in neurodegenerative conditions, particularly ...
Differentiating corticobasal syndrome (CBS) from progressive supranuclear palsy (PSP) and idiopathic...
Background: Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atro...
Background: Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atro...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
We investigated whether cerebrospinal fluid (CSF) analysis discriminates between idiopathic Parkinso...
Objective. To investigate the differences of candidate cerebrospinal fluid (CSF) biomarkers associat...
Contains fulltext : 52941.pdf (publisher's version ) (Closed access)BACKGROUND: Mu...
BACKGROUND: In early disease stages it can be clinically difficult to differentiate idiopathic Parki...
Contains fulltext : 52942.pdf (publisher's version ) (Closed access)BACKGROUND: In...
BACKGROUND: Multiple system atrophy (MSA) can clinically be divided into the cerebellar (MSA-C) and ...
Contains fulltext : 97710.pdf (publisher's version ) (Closed access)Differentiatin...
Background: Parkinson’s disease (PD) and atypical parkinsonian disorders (APD) [multiple system atro...
Introduction: Neuroinflammation is a potential player in neurodegenerative conditions, particularly ...
Differentiating corticobasal syndrome (CBS) from progressive supranuclear palsy (PSP) and idiopathic...
Background: Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atro...
Background: Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atro...